MATTHEW STINSON: Open Payments
NPI 1861828865 · GLENWOOD SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 19 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $143 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Insmed, Inc. | 3 | $80 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Pulmonx Corporation | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: TEZSPIRE, Arikayce, WINREVAIR, FASENRA, TRELEGY ELLIPTA, DUPIXENT, ZEPHYR DELIVERY CATHETER, YUPELRI.
Industry payments across CO — which companies pay providers there.
